The mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor.
AffiliationCancer Research Campaign & University of Manchester Department of Medical Oncology, Christie Hospital NHS Trust, Manchester M20 4BX, United Kingdom. MLyon@picr.man.ac.uk
MetadataShow full item record
AbstractHepatocyte growth factor/scatter factor, in addition to binding to its specific signal-transducing receptor, Met, also interacts with both heparan and dermatan sulfates with high affinity. We have investigated the comparative role of these two glycosaminoglycans in the activation of Met by hepatocyte growth factor/scatter factor. Using glycosaminoglycan-deficient CHO pgsA-745 cells we have shown that growth factor activity is critically dependent upon glycosaminoglycans, and that heparan sulfate and dermatan sulfate are equally potent as co-receptors. Cross-linked 1:1 conjugates of growth factor and either heparan or dermatan sulfate do not dimerize under physiological conditions and are biologically active. This implies that a ternary signaling complex with Met forms in vivo. Native Met isolated from CHO pgsA-745 cells shows only very weak intrinsic affinity for heparin in vitro. Also, a heparin-derived hexasaccharide, which is the minimal size for high affinity binding to the growth factor alone, is sufficient to induce biological activity. Together these observations imply that the role of these glycosaminoglycan may be primarily to effect a conformational change in hepatocyte growth factor/scatter factor, rather than to induce a necessary growth factor dimerization, or to stabilize a ternary complex by additionally interacting with Met.
CitationThe mode of action of heparan and dermatan sulfates in the regulation of hepatocyte growth factor/scatter factor. 2002, 277 (2):1040-6 J. Biol. Chem.
JournalThe Journal of Biological Chemistry
- The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides.
- Authors: Lyon M, Deakin JA, Lietha D, Gherardi E, Gallagher JT
- Issue date: 2004 Oct 15
- The binding properties of minimal oligosaccharides reveal a common heparan sulfate/dermatan sulfate-binding site in hepatocyte growth factor/scatter factor that can accommodate a wide variety of sulfation patterns.
- Authors: Deakin JA, Blaum BS, Gallagher JT, Uhrín D, Lyon M
- Issue date: 2009 Mar 6
- Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. Heparan sulfate glycosaminoglycan requirement for Met binding and signaling.
- Authors: Sakata H, Stahl SJ, Taylor WG, Rosenberg JM, Sakaguchi K, Wingfield PT, Rubin JS
- Issue date: 1997 Apr 4
- Hepatocyte growth factor/scatter factor and its interaction with heparan sulphate and dermatan sulphate.
- Authors: Catlow K, Deakin JA, Delehedde M, Fernig DG, Gallagher JT, Pavão MS, Lyon M
- Issue date: 2003 Apr
- Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
- Authors: Rubin JS, Day RM, Breckenridge D, Atabey N, Taylor WG, Stahl SJ, Wingfield PT, Kaufman JD, Schwall R, Bottaro DP
- Issue date: 2001 Aug 31